ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
4,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
6,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
6,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
7,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,2,Pregnancy on oral contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
9,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
9,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
10,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
10,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
11,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
12,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
13,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
13,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
13,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
14,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
15,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
16,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
16,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
18,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
19,1,Myopathy,Myopathies,Muscle disorders,Musc,N
20,1,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
21,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
22,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
23,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
23,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
23,3,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
24,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
25,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
26,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
27,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
28,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
28,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
29,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
30,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
30,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
31,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
31,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
31,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
31,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
32,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
33,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
33,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
34,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
35,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
36,1,Morphoea,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
37,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
38,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
39,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
39,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
40,1,Deafness,Hearing losses,Hearing disorders,Ear,N
41,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
41,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
42,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
42,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
43,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
44,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
44,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
44,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
44,4,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
45,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
45,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
45,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
46,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
47,1,Device colour issue,Device physical property and chemical issues,Device issues,Prod,N
48,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
49,1,Retinal vascular disorder,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
50,1,Paroxysmal nocturnal haemoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
50,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
51,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
51,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
52,1,Chronic cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
52,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
54,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
55,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
56,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
57,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
57,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
58,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
59,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
60,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
61,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
62,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
63,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
63,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
63,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
63,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
64,1,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
65,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
66,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
66,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
69,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
69,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
69,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
70,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
70,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
71,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
72,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
72,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
73,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
74,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
75,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
76,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
77,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,1,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
79,1,Enamel anomaly,Dental surface disorders,Dental and gingival conditions,Gastr,N
80,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
81,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
81,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
82,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
82,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
83,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
84,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
84,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
85,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
86,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
86,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
87,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
88,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
89,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
90,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
90,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
91,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,1,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
93,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
94,1,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
94,2,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
95,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
95,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
96,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
97,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
99,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
99,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
100,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
101,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
102,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
102,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
104,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
104,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
105,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
105,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
106,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
107,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
108,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
109,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
109,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
110,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
110,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
110,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
111,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
112,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
113,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
114,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
115,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
116,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
117,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
118,1,Deafness,Hearing losses,Hearing disorders,Ear,N
119,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
120,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
120,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
121,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
122,1,Retinal vascular disorder,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
123,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
124,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
125,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
125,2,Cranial nerve disorder,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
126,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
127,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
128,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
128,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
129,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
130,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
131,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
131,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
132,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
133,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
134,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
135,1,Myopathy,Myopathies,Muscle disorders,Musc,N
135,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
136,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
136,2,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
137,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
137,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
137,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
138,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
138,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
138,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
139,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
140,2,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
140,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
140,4,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
140,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
141,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
141,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
143,1,Headache,Headaches NEC,Headaches,Nerv,N
144,1,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
144,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
145,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
145,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
146,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
146,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
146,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
147,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
149,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
150,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
151,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
152,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
152,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
153,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
154,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
154,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
155,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
156,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
157,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
158,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
158,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
159,1,Myopathy,Myopathies,Muscle disorders,Musc,N
160,1,Headache,Headaches NEC,Headaches,Nerv,N
161,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
162,1,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
162,2,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
162,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
163,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
164,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
165,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
165,2,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
166,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
167,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
168,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
169,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
170,1,Deafness,Hearing losses,Hearing disorders,Ear,N
170,2,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
170,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
171,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
172,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
173,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
174,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
175,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
175,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
175,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
176,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
177,1,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
177,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
178,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
179,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
179,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
179,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
180,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
181,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
181,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
181,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
182,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
182,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
182,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
182,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
182,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
183,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
183,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
184,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
185,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
186,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
187,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
188,1,Hepatic haemorrhage,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
188,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
188,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
189,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
190,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
190,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
190,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
191,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
192,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
193,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
194,1,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
194,2,Cardiac septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
194,3,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
195,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
196,1,Retinal deposits,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
197,1,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
198,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
199,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
200,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
200,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
202,1,Retinal deposits,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
202,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
202,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
203,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
203,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
203,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
204,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
204,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
204,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
205,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
206,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
207,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
207,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
208,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
208,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
209,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
210,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
211,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
212,1,Holoprosencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
213,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
213,2,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
214,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
215,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
216,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
217,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
218,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
219,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
220,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
221,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
221,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
222,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
223,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
224,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
224,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
224,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
225,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
226,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
227,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
227,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
227,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
227,4,Mitral valve disease,Mitral valvular disorders,Cardiac valve disorders,Card,N
227,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
227,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
227,7,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
227,8,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
228,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
229,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
229,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
230,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
230,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
231,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
232,1,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
233,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
233,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
234,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
234,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
235,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
236,1,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
237,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
238,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
239,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
240,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
240,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
240,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
241,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
241,2,Paraesthesia mucosal,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
241,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
241,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
242,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
242,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
242,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
242,4,Headache,Headaches NEC,Headaches,Nerv,N
243,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
244,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
244,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
245,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
246,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
247,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
248,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
249,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
249,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
250,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
250,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
250,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
250,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
251,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
252,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
252,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
253,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
253,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
253,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
253,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
253,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
254,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
255,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
255,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
255,3,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
256,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
258,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
259,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
259,2,"Hallucination, gustatory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
259,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
259,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
260,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
260,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
260,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
260,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
260,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
260,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
260,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
261,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
262,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
262,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
262,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
262,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
262,5,Headache,Headaches NEC,Headaches,Nerv,N
262,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
262,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
262,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
263,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
264,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
264,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
264,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
265,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
266,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
267,1,Obstructive pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
268,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
269,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
269,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
269,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
269,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
270,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
271,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
272,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
272,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
273,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
273,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
274,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
274,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
275,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
276,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
276,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
276,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
276,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
277,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
277,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
278,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
279,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
280,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
280,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
281,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
282,1,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
283,1,Oscillopsia,Visual disorders NEC,Vision disorders,Eye,N
284,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
284,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
285,1,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
286,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
287,1,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
287,2,Ocular toxicity,Ocular injuries NEC,Ocular injuries,Eye,N
288,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
289,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
289,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
289,3,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
290,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
290,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
291,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
292,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
292,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
292,3,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
292,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
292,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
292,6,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
292,7,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
292,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
292,9,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
292,10,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
292,11,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
292,12,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
292,13,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
292,14,Headache,Headaches NEC,Headaches,Nerv,N
292,15,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
292,16,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
292,17,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
292,18,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
292,19,Laryngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
292,20,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
292,21,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
292,22,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
292,23,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
292,24,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
292,25,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
292,26,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
292,27,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
292,28,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
292,29,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
292,30,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
292,31,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
292,32,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
292,33,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
292,34,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
292,35,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
293,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
293,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
294,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
294,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
294,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
294,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
294,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
294,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
295,1,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
296,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
296,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
297,1,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
298,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
299,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
299,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
299,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
299,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
300,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
300,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
300,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
300,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
300,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
301,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
301,2,Myopathy,Myopathies,Muscle disorders,Musc,N
301,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
301,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
302,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
302,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
302,3,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
302,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
303,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
303,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
303,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
304,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
305,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
306,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
306,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
306,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
306,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
307,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
308,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
309,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
310,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
310,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
311,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
312,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
312,2,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
313,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
313,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
313,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
313,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
313,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
313,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
313,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
313,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
313,9,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
313,10,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
313,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
313,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
314,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
315,1,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
315,2,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
315,3,Lipid metabolism disorder,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
315,4,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
315,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
316,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
317,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
317,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
317,3,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
318,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
318,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
318,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
319,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
319,2,Headache,Headaches NEC,Headaches,Nerv,N
319,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
319,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
319,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
319,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
319,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
320,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
320,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
320,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
320,4,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
321,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
322,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
323,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
323,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
324,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
325,1,Colon neoplasm,Colorectal and anal neoplasms malignancy unspecified,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
326,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
327,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
327,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
327,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
328,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
328,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
328,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
329,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
329,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
329,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
330,1,Pupillary disorder,Pupil disorders,Ocular neuromuscular disorders,Eye,N
331,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
331,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
331,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
331,4,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
331,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
331,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
331,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
332,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
333,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
333,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
333,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
333,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
333,5,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
334,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
335,1,Headache,Headaches NEC,Headaches,Nerv,N
335,2,Iris hyperpigmentation,"Iris and ciliary body structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
335,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
335,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
336,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
337,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
337,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
337,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
338,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
339,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
340,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
341,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
341,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
341,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
341,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
341,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
342,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
342,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
342,3,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
342,4,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
342,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
342,6,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
342,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
342,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
342,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
343,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
343,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
343,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
343,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
344,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
344,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
345,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
346,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
346,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
346,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
347,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
348,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
349,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
349,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
349,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
349,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
350,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
350,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
350,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
351,1,Deafness,Hearing losses,Hearing disorders,Ear,N
351,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
352,1,Cleft lip and palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
352,2,Teratogenicity,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
353,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
354,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
355,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
355,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
355,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
355,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
355,5,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
356,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
357,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
358,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
358,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
359,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
360,1,Presbyacusis,Hearing losses,Hearing disorders,Ear,N
361,1,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
361,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
362,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
363,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
364,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
364,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
364,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
365,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
365,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
366,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
366,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
367,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
367,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
367,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
367,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
367,5,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
367,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
367,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
367,8,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
367,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
367,10,Restrictive cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
367,11,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
367,12,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
368,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
368,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
368,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
368,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
369,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
369,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
370,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
371,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
372,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
372,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
372,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
372,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
373,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
374,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
374,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
374,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
375,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
376,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
377,1,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
378,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
379,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
379,2,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
379,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
379,4,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
380,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
380,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
380,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
381,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
382,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
382,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
382,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
383,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
384,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
384,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
385,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
385,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
385,3,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
385,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
386,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
387,1,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
388,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
388,2,Reading disorder,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
389,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
390,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
390,2,Mycoplasma infection,Mycoplasma infections,Mycoplasmal infectious disorders,Infec,N
391,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
391,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
392,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
393,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
393,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
393,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
393,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
393,5,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
393,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
394,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
394,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
395,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
395,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
396,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
396,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
396,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
396,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
396,5,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
396,6,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
396,7,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
396,8,Oesophageal varices haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
396,9,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
397,1,Deafness,Hearing losses,Hearing disorders,Ear,N
398,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
398,2,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
398,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
398,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
398,5,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
398,6,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
398,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
399,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
400,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
401,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
401,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
401,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
401,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
402,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
402,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
402,3,Sudden hearing loss,Hearing losses,Hearing disorders,Ear,N
403,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
403,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
403,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
403,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
403,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
404,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
404,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
404,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
404,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
404,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
404,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
404,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
405,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
406,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
406,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
406,3,Pituitary tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
407,1,Capillaritis,Skin vasculitides,Skin vascular abnormalities,Skin,N
407,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
407,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
408,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
409,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
409,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
409,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
409,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
410,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
410,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
410,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
410,4,Headache,Headaches NEC,Headaches,Nerv,N
410,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
410,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
410,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
410,8,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
410,9,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
410,10,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
410,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
411,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
411,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
411,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
411,4,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
411,5,Prostate tenderness,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
411,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
411,7,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
412,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
412,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
412,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
412,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
413,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
413,2,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
413,3,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
413,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
413,5,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
414,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
414,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
414,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
414,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
414,5,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
415,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
415,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
415,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
415,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
415,5,Dyspnoea at rest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
415,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
415,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
415,8,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
416,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
416,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
417,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
417,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
417,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
417,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
418,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
418,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
419,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
419,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
419,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
420,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
420,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
420,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
420,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
420,5,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
421,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
421,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
421,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
422,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
423,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
424,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
424,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
424,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
425,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
425,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
425,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
426,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
426,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
427,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
427,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
428,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
429,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
429,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
430,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
430,2,Oesophageal spasm,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
431,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
431,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
432,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
432,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
432,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
432,4,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
432,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
432,6,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
432,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
432,8,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
432,9,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
433,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
433,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
434,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
435,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
435,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
435,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
436,1,Macular pigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
437,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
437,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
437,3,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
437,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
437,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
437,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
437,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
438,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
438,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
438,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
438,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
438,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
438,6,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
438,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
439,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
439,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
440,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
441,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
441,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
441,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
442,1,Fibrous histiocytoma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
443,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
443,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
443,3,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
443,4,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
443,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
444,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
444,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
444,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
444,4,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
444,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
444,6,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
445,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
445,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
445,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
445,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
445,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
445,6,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
445,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
445,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
445,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
445,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
445,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
445,12,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
445,13,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
445,14,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
446,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
447,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
447,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
447,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
447,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
447,5,Post inflammatory pigmentation change,Pigmentation changes NEC,Pigmentation disorders,Skin,N
447,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
447,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
447,8,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
447,9,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
447,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
447,11,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
448,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
448,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
448,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
448,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
448,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
449,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
450,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
450,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
450,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
450,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
450,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
450,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
450,7,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
450,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
451,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
451,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
451,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
451,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
451,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
451,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
452,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
452,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
452,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
452,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
453,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
453,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
453,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
454,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
455,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
455,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
456,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
456,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
457,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
457,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
457,3,Oesophageal spasm,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
458,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
459,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
459,2,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
459,3,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
459,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
459,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
459,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
459,7,Headache,Headaches NEC,Headaches,Nerv,N
459,8,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
459,9,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
459,10,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
459,11,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
459,12,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
459,13,Migraine,Migraine headaches,Headaches,Nerv,N
459,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
459,15,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
459,16,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
460,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
460,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
460,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
460,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
461,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
461,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
462,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
462,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
462,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
462,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
462,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
462,6,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
462,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
462,8,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
462,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
463,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
464,1,Acute stress disorder,Stress disorders,Anxiety disorders and symptoms,Psych,N
464,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
464,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
464,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
464,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
464,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
465,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
465,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
465,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
465,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
465,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
465,6,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
465,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
465,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
466,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
467,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
467,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
467,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
467,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
467,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
468,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
469,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
470,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
470,2,Headache,Headaches NEC,Headaches,Nerv,N
470,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
470,4,Sleep talking,Parasomnias,Sleep disorders and disturbances,Psych,N
470,5,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
471,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
472,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
472,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
473,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
474,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
474,2,Product coating issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
475,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
475,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
475,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
475,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
475,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
475,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
476,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
476,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
476,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
476,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
476,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
477,1,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
477,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
477,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
478,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
478,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
478,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
479,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
479,2,Amyloidosis,Amyloidoses,Immune disorders NEC,Immun,N
479,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
479,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
480,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,Y
480,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
480,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
480,4,Vascular injury,Cardiovascular injuries,Injuries NEC,Inj&P,N
480,5,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
481,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
481,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
481,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
482,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
482,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
482,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
483,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
483,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
484,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
484,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
484,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
485,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
485,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
485,3,Tendon disorder,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
485,4,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
486,1,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
486,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
487,1,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
487,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
487,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
488,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
488,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
488,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
489,1,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
489,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
489,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
490,1,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
490,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
490,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
491,1,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
491,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
491,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
492,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
492,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
492,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
492,4,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
493,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
494,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
494,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
494,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
494,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
494,5,Headache,Headaches NEC,Headaches,Nerv,N
494,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
494,7,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
494,8,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
494,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
494,10,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
495,1,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
495,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
495,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
495,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
496,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
497,1,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
498,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
499,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
500,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
501,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
501,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
502,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
502,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
502,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
502,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
503,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
504,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
505,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
505,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
506,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
506,2,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
506,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
506,4,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
506,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
506,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
506,7,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
506,8,Migraine with aura,Migraine headaches,Headaches,Nerv,N
507,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
507,2,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
507,3,Oesophageal ulcer haemorrhage,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
507,4,Small intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
508,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
508,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
508,3,Dyspareunia,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
508,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
508,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
508,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
508,7,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
508,8,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
508,9,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
508,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
508,11,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
509,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
509,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
510,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
511,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
511,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
511,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
512,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
512,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
512,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
512,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
512,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
512,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
512,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
512,8,Post herpetic neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
512,9,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
512,10,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
513,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
513,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
514,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
515,1,Foetal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
515,2,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
516,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
516,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
517,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
517,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
517,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
517,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
517,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
518,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
518,2,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
519,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
520,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
521,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
521,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
522,1,Migraine,Migraine headaches,Headaches,Nerv,N
523,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
523,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
523,3,Headache,Headaches NEC,Headaches,Nerv,N
523,4,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
523,5,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
523,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
524,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
524,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
524,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
525,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
525,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
525,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
525,4,Urticaria papular,Urticarias,Angioedema and urticaria,Skin,N
526,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
527,1,Myopathy,Myopathies,Muscle disorders,Musc,N
528,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
529,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
530,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
530,2,Retinal phototoxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
531,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
531,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
531,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
532,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
533,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
534,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
534,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
534,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
535,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
535,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
535,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
535,4,Headache,Headaches NEC,Headaches,Nerv,N
535,5,Pathological fracture,Fractures NEC,Fractures,Musc,N
536,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
536,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
536,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
536,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
536,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
536,6,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
536,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
536,8,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
537,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
538,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
538,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
539,1,Myopia,Refractive and accommodative disorders,Vision disorders,Eye,N
539,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
539,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
540,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
540,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
540,3,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
540,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
540,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
540,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
540,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
540,8,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
541,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
541,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
541,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
541,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
541,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
541,6,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
541,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
542,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
542,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
543,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
544,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
545,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
545,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
545,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
546,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
547,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
548,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
549,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
549,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
550,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
550,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
550,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
551,1,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
552,1,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
553,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
553,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
554,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
554,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
554,3,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
554,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
555,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
555,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
555,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
555,4,Headache,Headaches NEC,Headaches,Nerv,N
555,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
555,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
555,7,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
555,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
556,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
556,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
557,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
557,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
558,1,Colour blindness,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
558,2,Retinal pigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
558,3,Retinitis pigmentosa,Retinal disorders congenital,Eye disorders congenital,Cong,N
558,4,Visual field defect,Visual field disorders,Vision disorders,Eye,N
559,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
560,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
561,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
561,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
562,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
562,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
563,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
564,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
565,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
565,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
565,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
566,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
567,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
567,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
567,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
567,4,Headache,Headaches NEC,Headaches,Nerv,N
567,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
567,6,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
568,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
569,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
569,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
570,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
570,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
570,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
571,1,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
571,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
571,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
572,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
572,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
572,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
572,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
572,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
573,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
574,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
574,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
575,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
575,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
575,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
575,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
576,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
576,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
577,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
577,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
577,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
577,4,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
577,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
577,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
578,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
578,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
579,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
580,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
580,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
580,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
580,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
581,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
581,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
582,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
582,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
582,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
582,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
582,5,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
583,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
584,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
584,2,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
584,3,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
584,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
584,5,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
584,6,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
584,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
585,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
586,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
586,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
586,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
587,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
587,2,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
587,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
587,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
588,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
589,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
589,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
590,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
591,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
592,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
592,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
592,3,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
592,4,Coccydynia,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
592,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
592,6,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
592,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
592,8,Neurogenic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
592,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
592,10,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
592,11,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
593,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
593,2,Headache,Headaches NEC,Headaches,Nerv,N
593,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
594,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
595,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
595,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
595,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
595,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
595,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
595,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
595,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
595,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
595,9,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
595,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
595,11,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
595,12,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
596,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
597,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
598,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
598,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
598,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
598,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
598,5,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
598,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
598,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
598,8,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
599,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
599,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
600,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
600,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
600,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
601,1,Electrooculogram abnormal,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
601,2,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
601,3,Retinogram abnormal,Ophthalmic histopathology and imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
601,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
602,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
602,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
602,3,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
602,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
602,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
603,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
603,2,Migraine,Migraine headaches,Headaches,Nerv,N
604,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
604,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
604,3,Hair disorder,Pilar disorders NEC,Skin appendage conditions,Skin,N
605,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
606,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
606,2,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
607,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
608,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
608,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
609,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
610,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
610,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
610,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
611,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
611,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
611,3,Subacute cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
612,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
612,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
612,3,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
612,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
612,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
612,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
612,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
612,8,Systemic lupus erythematosus rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
613,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
614,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
614,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
614,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
614,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
614,5,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
614,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
615,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
615,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
615,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
615,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
615,5,Tinea pedis,Tinea infections,Fungal infectious disorders,Infec,N
615,6,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
616,1,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
617,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
617,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
618,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
618,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
618,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
619,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
620,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
620,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
620,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
620,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
620,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
621,1,Fundoscopy abnormal,Ophthalmic histopathology and imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
621,2,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
621,3,Optical coherence tomography abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
622,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
622,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
623,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
623,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
623,3,Headache,Headaches NEC,Headaches,Nerv,N
623,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
624,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
625,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
626,1,Urethral pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
627,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
627,2,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
628,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
628,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
628,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
629,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
629,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
629,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
629,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
629,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
629,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
630,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
631,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
631,2,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
631,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
631,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
632,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
632,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
632,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
632,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
632,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
633,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
634,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
634,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
634,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
634,4,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
634,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
634,6,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
634,7,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
634,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
634,9,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
634,10,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
634,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
634,12,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
634,13,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
634,14,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
634,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
634,16,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
634,17,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
634,18,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
634,19,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
634,20,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
634,21,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
634,22,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
634,23,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
634,24,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
635,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
636,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
636,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
636,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
636,4,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
637,1,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
637,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
638,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
638,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
638,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
638,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
638,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
638,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
639,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
639,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
639,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
639,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
639,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
640,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
641,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
641,2,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
642,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
642,2,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
642,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
642,4,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
642,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
642,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
642,7,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
642,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
642,9,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
642,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
643,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
643,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
643,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
643,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
643,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
644,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
645,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
645,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
645,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
645,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
646,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
647,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
647,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
647,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
648,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
648,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
649,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
649,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
649,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
650,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
650,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
651,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
652,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
653,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
653,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
653,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
654,1,Photodermatosis,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
654,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
655,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
655,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
655,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
655,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
656,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
656,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
657,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
657,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
657,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
658,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
658,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
658,3,Headache,Headaches NEC,Headaches,Nerv,N
658,4,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
658,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
658,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
658,7,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
659,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
659,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
659,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
660,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
660,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
660,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
661,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
662,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
663,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
663,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
664,1,Ophthalmic herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
665,1,Biopsy skin abnormal,Skin histopathology and skin investigations NEC,Skin investigations,Inv,N
665,2,Lyme disease,Borrelial infections,Bacterial infectious disorders,Infec,N
665,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
666,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
666,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
667,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
668,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
668,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
668,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
669,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
670,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
670,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
670,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
670,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
671,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
671,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
672,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
672,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
672,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
672,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
672,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
673,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
674,1,Glare,Visual disorders NEC,Vision disorders,Eye,N
674,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
674,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
675,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
676,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
676,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
676,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
676,4,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
676,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
676,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
676,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
676,8,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
676,9,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
676,10,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
677,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
678,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
678,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
678,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
679,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
680,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
680,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
680,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
680,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
680,5,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
680,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
680,7,Impulsive behaviour,Impulse control disorders,Impulse control disorders NEC,Psych,N
680,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
680,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
680,10,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
680,11,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
680,12,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
681,1,Acute haemorrhagic leukoencephalitis,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
681,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
681,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
681,4,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
681,5,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
681,6,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
681,7,Cerebral mass effect,Structural brain disorders NEC,Structural brain disorders,Nerv,N
681,8,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
681,9,Culture tissue specimen positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
681,10,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
681,11,Intracranial mass,Structural brain disorders NEC,Structural brain disorders,Nerv,N
681,12,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
682,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
682,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
683,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
684,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
685,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
685,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
685,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
685,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
685,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
685,6,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
685,7,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
685,8,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
686,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
686,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
686,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
686,4,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
687,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
687,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
687,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
687,4,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
688,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
688,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
688,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
689,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
689,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
689,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
689,4,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
690,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
690,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
691,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
692,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
692,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
692,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
692,4,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
692,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
692,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
693,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
693,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
693,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
693,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
694,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
695,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
696,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
696,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
697,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
697,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
697,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
697,4,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
697,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
697,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
697,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
698,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
698,2,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
698,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
698,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
699,1,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
699,2,Headache,Headaches NEC,Headaches,Nerv,N
699,3,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
699,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
700,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
701,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
701,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
701,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
702,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
702,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
702,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
702,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
702,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
702,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
702,7,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
703,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
703,2,Headache,Headaches NEC,Headaches,Nerv,N
703,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
703,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
704,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
705,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
706,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
707,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
708,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
709,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
710,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
711,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
712,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
713,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
714,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
715,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
716,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
716,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
716,3,Headache,Headaches NEC,Headaches,Nerv,N
716,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
716,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
716,6,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
717,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
718,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
719,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
719,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
719,3,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
719,4,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
719,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
719,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
719,7,Visual field defect,Visual field disorders,Vision disorders,Eye,N
720,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
720,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
721,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
722,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
723,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
723,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
724,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
724,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
724,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
724,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
724,5,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
724,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
725,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
726,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
727,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
727,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
728,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
728,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
729,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
729,2,Headache,Headaches NEC,Headaches,Nerv,N
729,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
729,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
729,5,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
729,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
730,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
730,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
731,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
731,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
731,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
732,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
732,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
732,3,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
733,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
733,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
734,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
735,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
735,2,Epiglottitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
735,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
735,4,Oropharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
736,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
736,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
737,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
738,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
738,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
738,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
739,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
739,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
739,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
740,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
741,1,Headache,Headaches NEC,Headaches,Nerv,N
741,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
742,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
742,2,Flat affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
743,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
743,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
743,3,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
743,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
743,5,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
743,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
743,7,Migraine,Migraine headaches,Headaches,Nerv,N
743,8,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
743,9,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
743,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
743,11,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
744,1,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
745,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
745,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
745,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
745,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
746,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
746,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
747,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
748,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
748,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
748,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
748,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
748,5,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
748,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
748,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
748,8,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
748,9,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
748,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
748,11,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
748,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
748,13,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
748,14,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
748,15,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
748,16,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
748,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
749,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
750,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
750,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
751,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
751,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
751,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
751,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
751,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
751,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
751,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
751,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
752,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
752,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
752,3,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
752,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
752,5,Visual field defect,Visual field disorders,Vision disorders,Eye,N
753,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
754,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
754,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
755,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
755,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
756,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
756,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
757,1,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
757,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
757,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
757,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
758,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
759,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
760,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
760,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
761,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
761,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
762,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
762,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
762,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
763,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
763,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
763,3,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
763,4,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
763,5,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
763,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
763,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
763,8,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
763,9,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
763,10,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
763,11,Palpable purpura,Skin vasculitides,Skin vascular abnormalities,Skin,N
763,12,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
763,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
763,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
763,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
763,16,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
763,17,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
763,18,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
764,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
764,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
764,3,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
764,4,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
764,5,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
764,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
764,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
764,8,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
764,9,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
764,10,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
764,11,Palpable purpura,Skin vasculitides,Skin vascular abnormalities,Skin,N
764,12,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
764,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
764,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
764,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
764,16,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
764,17,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
764,18,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
764,19,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
765,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
765,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
766,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
766,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
767,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
767,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
767,3,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
767,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
768,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
768,2,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
768,3,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
768,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
768,5,Cyanopsia,Visual colour distortions,Vision disorders,Eye,N
768,6,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
768,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
768,8,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
768,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
768,10,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
768,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
768,12,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
769,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
769,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
770,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
771,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
771,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
772,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
772,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
773,1,Bloody discharge,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
773,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
773,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
773,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
773,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
773,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
773,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
773,8,International normalised ratio fluctuation,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
773,9,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
773,10,Lyme disease,Borrelial infections,Bacterial infectious disorders,Infec,N
773,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
773,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
773,13,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
773,14,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
773,15,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
773,16,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
773,17,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
773,18,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
773,19,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
774,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
775,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
775,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
775,3,Electrocardiogram PR prolongation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
775,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
776,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
776,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
777,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
777,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
777,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
777,4,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
777,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
778,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
778,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
778,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
779,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
780,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
781,1,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
781,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
781,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
782,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
783,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
783,2,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
783,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
783,4,Headache,Headaches NEC,Headaches,Nerv,N
783,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
784,1,Anal hypoaesthesia,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
784,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
784,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
784,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
784,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
784,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
784,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
784,8,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
784,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
784,10,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
784,11,Urine flow decreased,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
785,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
785,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
785,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
785,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
785,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
786,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
787,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
787,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
787,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
787,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
788,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
788,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
788,3,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
789,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
790,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
790,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
790,3,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
791,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
792,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
793,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
794,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
794,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
794,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
794,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
794,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
795,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
795,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
795,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
795,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
795,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
795,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
795,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
796,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
796,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
797,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
797,2,Retinal pigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
798,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
799,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
799,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
800,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
801,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
801,2,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
801,3,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
801,4,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
802,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
802,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
803,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
804,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
805,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
805,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
805,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
805,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
805,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
805,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
806,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
806,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
807,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
807,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
807,3,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
807,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
808,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
808,2,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
808,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
809,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
809,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
810,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
810,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
810,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
810,4,Hyperinsulinaemic hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
810,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
811,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
811,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
811,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
812,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
812,2,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
813,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
814,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
814,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
814,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
815,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
816,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
817,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
818,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
819,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
820,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
821,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
822,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
823,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
824,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
824,2,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
824,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
824,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
825,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
825,2,Haemolysis neonatal,Haemolyses NEC,Haemolyses and related conditions,Blood,N
825,3,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
825,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
826,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
826,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
826,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
826,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
826,5,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
826,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
826,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
826,8,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
826,9,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
826,10,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
826,11,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
827,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
827,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
827,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
828,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
828,2,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
828,3,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
828,4,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
828,5,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
828,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
828,7,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
828,8,Dyspnoea at rest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
828,9,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
828,10,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
828,11,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
828,12,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
828,13,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
828,14,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
828,15,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
828,16,Right atrial enlargement,Myocardial disorders NEC,Myocardial disorders,Card,N
829,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
830,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
831,1,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
831,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
832,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
832,2,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
832,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
832,4,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
832,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
832,6,Right atrial enlargement,Myocardial disorders NEC,Myocardial disorders,Card,N
833,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
834,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
834,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
834,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
834,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
834,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
834,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
835,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
836,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
836,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
837,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
838,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
839,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
840,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
840,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
840,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
841,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
841,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
841,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
841,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
841,5,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
841,6,Subacute cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
842,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
843,1,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
844,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
845,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
845,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
846,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
846,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
847,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
847,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
847,3,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
847,4,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
848,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
849,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
849,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
849,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
850,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
851,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
852,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
852,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
852,3,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
853,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
854,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
855,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
856,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
856,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
856,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
856,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
856,5,Headache,Headaches NEC,Headaches,Nerv,N
856,6,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
857,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
857,2,Genital infection,Infections NEC,Infections - pathogen unspecified,Infec,N
857,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
857,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
858,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
858,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
858,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
859,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
859,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
859,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
860,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
860,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
861,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
861,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
861,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
861,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
861,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
862,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
863,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
863,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
864,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
865,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
865,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
866,1,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
867,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
867,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
867,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
867,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
867,5,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
867,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
867,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
868,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
868,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
869,1,Ocular toxicity,Ocular injuries NEC,Ocular injuries,Eye,N
869,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
870,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
870,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
871,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
871,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
871,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
871,4,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
872,1,Migraine,Migraine headaches,Headaches,Nerv,N
872,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
873,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
873,2,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
873,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
873,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
873,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
873,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
874,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
875,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
875,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
875,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
875,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
875,5,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
876,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
876,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
876,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
876,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
876,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
876,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
877,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
877,2,Headache,Headaches NEC,Headaches,Nerv,N
877,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
877,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
878,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
878,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
878,3,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
878,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
878,5,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
878,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
878,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
879,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
879,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
879,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
880,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
880,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
881,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
881,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
881,3,Pulmonary haemosiderosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
881,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
882,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
883,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
883,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
884,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
884,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
884,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
885,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
885,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
885,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
886,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
886,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
886,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
886,4,Nail deformation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
886,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
886,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
887,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
887,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
888,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
888,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
888,3,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
888,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
889,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
889,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
889,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
889,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
889,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
889,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
889,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
889,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
889,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
890,1,Central nervous system lupus,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
890,2,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
890,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
890,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
890,5,Meningitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,N
890,6,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
891,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
891,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
891,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
892,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
893,1,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
893,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
894,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
894,2,Heart failure with preserved ejection fraction,Left ventricular failures,Heart failures,Card,N
894,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
895,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
896,1,Diffuse large B-cell lymphoma stage I,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
897,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
897,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
897,3,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
898,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
899,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
899,2,Headache,Headaches NEC,Headaches,Nerv,N
899,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
900,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
900,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
900,3,Headache,Headaches NEC,Headaches,Nerv,N
900,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
900,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
901,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
902,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
902,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
902,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
902,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
903,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
903,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
903,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
904,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
904,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
904,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
904,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
904,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
904,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
905,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
905,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
905,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
905,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
906,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
906,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
906,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
907,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
907,2,Dactylitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
907,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
907,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
907,5,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
907,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
907,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
907,8,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
907,9,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
907,10,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
907,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
907,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
907,13,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
907,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
907,15,Rheumatoid nodule,Rheumatoid arthropathies,Joint disorders,Musc,N
907,16,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
908,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
908,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
908,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
909,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
910,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
910,2,Headache,Headaches NEC,Headaches,Nerv,N
910,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
911,1,Febrile convulsion,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
911,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
912,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
912,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
912,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
913,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
913,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
914,1,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
914,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
915,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
915,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
916,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
917,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
918,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
918,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
918,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
918,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
919,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
920,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
920,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
921,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
922,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
922,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
922,3,Headache,Headaches NEC,Headaches,Nerv,N
923,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
924,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
925,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
925,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
925,3,Headache,Headaches NEC,Headaches,Nerv,N
925,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
925,5,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
926,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
926,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
927,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
928,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
928,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
928,3,Headache,Headaches NEC,Headaches,Nerv,N
928,4,Herbal interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
928,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
928,6,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
928,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
928,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
929,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
929,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
930,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
931,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
931,2,Brain herniation,Cerebral injuries NEC,Injuries NEC,Inj&P,N
931,3,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
931,4,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
931,5,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
931,6,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
931,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
931,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
932,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
933,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
933,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
934,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
935,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
936,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
936,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
936,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
937,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
937,2,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
937,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
938,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
939,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
939,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
940,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
940,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
941,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
941,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
941,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
941,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
941,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
942,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
942,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,Y
942,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
943,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
943,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
943,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
943,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
943,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
943,6,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
943,7,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
943,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
943,9,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
943,10,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
943,11,Meniscus injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
943,12,Mycobacterium tuberculosis complex test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
943,13,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
943,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
943,15,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
943,16,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
943,17,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
943,18,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
943,19,Rheumatoid nodule,Rheumatoid arthropathies,Joint disorders,Musc,N
943,20,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
943,21,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
943,22,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
944,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
944,2,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
945,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
946,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
947,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
947,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
947,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
948,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
949,1,Fibronectin,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
950,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
951,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
951,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
951,3,Headache,Headaches NEC,Headaches,Nerv,N
951,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
952,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
953,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
953,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
953,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
954,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
954,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
954,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
955,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
955,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
955,3,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
956,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
956,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
956,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
956,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
956,5,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
956,6,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
957,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
957,2,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
957,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
958,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
958,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
959,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
959,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
959,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
960,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
961,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
962,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
963,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
963,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
963,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
963,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
964,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
964,2,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
964,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
965,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
966,1,Pemphigus,Bullous conditions,Epidermal and dermal conditions,Skin,N
967,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
968,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
969,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
970,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
970,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
971,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
971,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
972,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
972,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
972,3,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
972,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
973,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
973,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
973,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
973,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
973,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
973,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
973,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
974,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
974,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
975,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
975,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
975,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
975,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
976,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
976,2,Headache,Headaches NEC,Headaches,Nerv,N
976,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
976,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
977,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
978,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
979,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
979,2,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
979,3,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
979,4,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
979,5,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
979,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
979,7,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
979,8,Dyspnoea at rest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
979,9,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
979,10,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
979,11,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
979,12,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
979,13,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
979,14,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
979,15,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
979,16,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
979,17,Right atrial enlargement,Myocardial disorders NEC,Myocardial disorders,Card,N
980,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
981,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
981,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
981,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
981,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
981,5,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
981,6,Headache,Headaches NEC,Headaches,Nerv,N
981,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
982,1,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
983,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
983,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
984,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
985,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
986,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
987,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
987,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
987,3,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
987,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
988,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
988,2,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
988,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
988,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
988,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
988,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
989,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
990,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
991,1,Unintentional use for unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
991,2,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
992,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
993,1,Food intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
993,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
993,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
994,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
994,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
995,1,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
996,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
996,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
996,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
997,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
998,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
999,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
999,2,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1000,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1001,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1002,1,Acquired pigmented retinopathy,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1002,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1003,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1003,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1003,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1003,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1003,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1004,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1004,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1004,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1004,4,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1004,5,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1005,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1006,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1007,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1007,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1007,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1008,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1009,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1010,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1011,1,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1011,2,Severe invasive streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1012,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1012,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1013,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1014,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1014,2,Headache,Headaches NEC,Headaches,Nerv,N
1014,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1014,4,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,Y
1014,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1014,6,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1014,7,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1014,8,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1014,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1015,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1015,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1015,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1015,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1015,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1015,6,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1015,7,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1015,8,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1015,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1016,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1016,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1016,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1016,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1016,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1016,6,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1016,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1017,1,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1017,2,Severe invasive streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1018,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1019,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1020,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1021,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1022,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1022,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1023,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1024,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1024,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1024,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1024,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1024,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1024,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1025,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1025,2,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1025,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1025,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1025,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1025,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1025,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1025,8,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1025,9,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1025,10,Headache,Headaches NEC,Headaches,Nerv,N
1025,11,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1025,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1025,13,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1025,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1025,15,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1026,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1026,2,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1026,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1027,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1028,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1029,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
1030,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1031,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1031,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1032,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1032,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1032,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1033,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1033,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1034,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1035,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1035,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1036,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1037,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1037,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1038,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1039,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1039,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1040,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1040,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1040,3,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1041,1,Cutaneous symptom,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1042,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1043,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1044,1,Erythema annulare,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
1044,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1045,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1045,2,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1046,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1046,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1046,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1046,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1046,5,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1046,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1046,7,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1046,8,Headache,Headaches NEC,Headaches,Nerv,N
1046,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1046,10,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1046,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1046,12,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1046,13,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1046,14,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1046,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1047,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1048,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1048,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1049,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1049,2,Manufacturing materials issue,Manufacturing materials issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1049,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1050,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1050,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1051,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1051,2,Dermatitis infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1051,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1051,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1051,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1051,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1051,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1051,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1051,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1052,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1053,1,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1053,2,Product coating issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1054,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1055,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1056,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1056,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1057,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1057,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1058,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1058,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1059,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1059,2,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1059,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1059,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1059,5,Epidermolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1059,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1059,7,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1059,8,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1059,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1059,10,Nikolsky's sign,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1059,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1059,12,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1059,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1059,14,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1059,15,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1060,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1060,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1060,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1060,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1061,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1061,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1062,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1062,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1063,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1064,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1064,2,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1064,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1064,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1064,5,Epidermolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1064,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1064,7,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1064,8,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1064,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1064,10,Nikolsky's sign,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1064,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1064,12,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1064,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1064,14,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1064,15,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1065,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1065,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1065,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1065,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1065,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1065,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1066,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1067,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1067,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1067,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1067,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1067,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1068,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1068,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1069,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1069,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1069,3,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1069,4,Cardiac failure chronic,Heart failures NEC,Heart failures,Card,N
1069,5,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1069,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1069,7,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1069,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1069,9,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1069,10,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1069,11,Right ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1070,1,Headache,Headaches NEC,Headaches,Nerv,N
1071,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1071,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1072,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1072,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1073,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1073,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1074,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1074,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1074,3,Headache,Headaches NEC,Headaches,Nerv,N
1074,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1075,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1075,2,Headache,Headaches NEC,Headaches,Nerv,N
1075,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1076,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1077,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1077,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1077,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1078,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1078,2,Headache,Headaches NEC,Headaches,Nerv,N
1078,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1078,4,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,Y
1079,1,Opiates positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
1080,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1080,2,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1080,3,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1080,4,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1080,5,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1080,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1080,7,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
1080,8,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
1080,9,Myopathy,Myopathies,Muscle disorders,Musc,N
1080,10,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1081,1,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1081,2,Cardiac failure chronic,Heart failures NEC,Heart failures,Card,N
1081,3,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1081,4,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1081,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1081,6,Right ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1082,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1082,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1082,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1083,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1083,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1084,1,Headache,Headaches NEC,Headaches,Nerv,N
1085,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1085,2,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1085,3,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1085,4,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1085,5,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1085,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1085,7,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
1085,8,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
1085,9,Myopathy,Myopathies,Muscle disorders,Musc,N
1085,10,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1086,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1086,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1086,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1087,1,Headache,Headaches NEC,Headaches,Nerv,N
1087,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1088,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1089,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1089,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1089,3,Headache,Headaches NEC,Headaches,Nerv,N
1089,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1090,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1091,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1092,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1093,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1093,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1094,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1095,1,Bundle branch block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1095,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1095,3,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1095,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1095,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1095,6,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1095,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1095,8,Toxic cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1096,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1096,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1096,3,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
1097,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1097,2,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
1098,1,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1098,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1098,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1098,4,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1098,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1098,6,Right ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1098,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1099,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1099,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1099,3,Headache,Headaches NEC,Headaches,Nerv,N
1099,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1099,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1099,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1099,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1099,8,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1100,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1100,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1100,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1100,4,Tendon discomfort,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1101,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1101,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1101,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1102,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1102,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1102,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1103,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1103,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1103,3,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
1103,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1103,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
1103,6,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1104,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1104,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1104,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1105,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1105,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1105,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1105,4,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
1106,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1106,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1106,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1107,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1107,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1108,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1108,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1108,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1108,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1108,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1109,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1110,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1111,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1111,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1111,3,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
1112,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1112,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1112,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1113,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1114,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1114,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1114,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1115,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1116,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1117,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1118,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1119,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1120,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1121,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1122,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1122,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1123,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
1123,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1123,3,Vaccination failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1124,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1124,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1125,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1125,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1126,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1126,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1126,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1126,4,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1127,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1127,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1128,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1128,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
1128,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1128,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1128,5,Vaccination failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1129,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1129,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1129,3,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1129,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1129,5,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1129,6,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1130,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1130,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1130,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1130,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1130,5,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1130,6,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1130,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1130,8,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1130,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1131,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1131,2,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
1131,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1131,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1132,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1132,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1133,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1133,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1133,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1133,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1134,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1134,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1134,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1134,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1135,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1136,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1136,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1136,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1136,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1137,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1138,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1138,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1139,1,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1140,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1141,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1142,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1143,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1143,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1144,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1145,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1145,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1145,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1145,4,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1146,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1146,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1147,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1148,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1148,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1148,3,Heart block congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
1148,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
1148,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1148,6,Rhythm idioventricular,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1148,7,Supraventricular extrasystoles,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1148,8,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1149,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1149,2,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1150,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1150,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1150,3,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1150,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1151,1,Calcinosis,Trophic disorders,Tissue disorders NEC,Genrl,N
1152,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1152,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1152,3,Systemic scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1152,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1153,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1154,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1155,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1155,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1156,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1157,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1158,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1158,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1159,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1159,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1159,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1159,4,Postprandial hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1159,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1159,6,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1159,7,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1160,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1160,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1161,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1162,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1163,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1163,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1164,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1164,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1164,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1164,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1164,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1165,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1165,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1166,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1166,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1166,3,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1167,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1167,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1167,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1167,4,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1167,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1168,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1169,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1170,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1170,2,Posterior capsule opacification,"Lens structural change, deposit and degeneration (excl cataracts)","Anterior eye structural change, deposit and degeneration",Eye,N
1170,3,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1171,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1172,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1173,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1174,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1175,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1175,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1175,3,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1175,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1176,1,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1177,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1177,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1177,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1177,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1177,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1177,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1177,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1177,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1177,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1178,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1178,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1179,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1179,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1179,3,Solar urticaria,Urticarias,Angioedema and urticaria,Skin,N
1180,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1180,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1180,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1180,4,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1181,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1181,2,Product blister packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1181,3,Product coating issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1182,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1182,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1183,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1183,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1183,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1184,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1184,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1184,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1185,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1185,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1185,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1185,4,Tongue dry,Tongue signs and symptoms,Tongue conditions,Gastr,N
1186,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1186,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1187,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1187,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1188,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1188,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1189,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1190,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1190,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1191,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1192,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1192,2,Hypertonic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
1192,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1193,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1193,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1193,3,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1193,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1193,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1194,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1194,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1194,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1195,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1195,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1196,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1196,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1196,3,Migraine,Migraine headaches,Headaches,Nerv,N
1197,1,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
1198,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
1198,2,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1198,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1198,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1198,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1198,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1198,7,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1199,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
1199,2,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1199,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1199,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1199,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1199,6,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1200,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
1200,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1200,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1200,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1201,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
1201,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1201,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1202,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1203,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1203,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1204,1,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1204,2,Subacute cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
1204,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1205,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1206,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1207,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1208,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1208,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1209,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1210,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1210,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1211,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1212,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1212,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1213,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1214,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1215,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1215,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1215,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1216,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1217,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1218,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1218,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1219,1,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1220,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1221,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1222,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1222,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1222,3,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1222,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1222,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1222,6,Headache,Headaches NEC,Headaches,Nerv,N
1222,7,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1223,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1224,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1225,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1226,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1226,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1227,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1228,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1228,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1229,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1229,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1230,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1230,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1230,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1230,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1231,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1232,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1233,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1234,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1235,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1236,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1236,2,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1236,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1236,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1237,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1237,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1238,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1239,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1239,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1240,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1240,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1241,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1241,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1241,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1242,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1243,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1243,2,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1243,3,Product coating issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1243,4,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1244,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1244,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1245,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1245,2,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1245,3,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1246,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1247,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1248,1,Multiple allergies,Allergic conditions NEC,Allergic conditions,Immun,N
1249,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1249,2,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1249,3,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1249,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1250,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,Y
1251,1,Retinal drusen,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1252,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1252,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1252,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1252,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1253,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1253,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1253,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1253,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1253,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1254,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1254,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1254,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1254,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1255,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1255,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1255,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1255,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1255,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1255,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1256,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1257,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1257,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1258,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1259,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1259,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1260,1,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1261,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1262,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1262,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1262,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1262,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1262,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1262,6,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1263,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1263,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1263,3,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1264,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1264,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1265,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1265,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1265,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1265,4,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1265,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1266,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1267,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1268,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1268,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1268,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1269,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1270,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1270,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1270,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1271,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1271,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1271,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1271,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1271,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1272,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1273,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1274,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1275,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1275,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1275,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1275,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1275,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1275,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1275,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1276,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1277,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1278,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1278,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1279,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1279,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1279,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1280,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1280,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1281,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1282,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1283,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1283,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1284,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1284,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1284,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1284,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1285,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1285,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1285,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1285,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1286,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1286,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1286,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1287,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1288,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1289,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1289,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1289,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1289,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1290,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1291,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1291,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1291,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1291,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1292,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1293,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1293,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1294,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1295,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1296,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1296,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1297,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1297,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1297,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1298,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1299,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1299,2,Chronic kidney disease-mineral and bone disorder,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1299,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1299,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1299,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1299,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1300,1,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1300,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1301,1,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1301,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1302,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1302,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1303,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1303,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1304,1,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1304,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1305,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1306,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1306,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1307,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1307,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1307,3,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
1308,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1309,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1309,2,Superinfection,Infections NEC,Infections - pathogen unspecified,Infec,N
1310,1,Vascular occlusion,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1311,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1312,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1312,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1312,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1313,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1313,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1313,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1314,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1314,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1315,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1315,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1315,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1315,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1316,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
1317,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1318,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
